Products

Merck Animal Health is committed to protecting the health of animals and supporting a safe and affordable food supply. Through our broad portfolio of vaccines, therapeutic medicines, parasiticides, and technology solutions, we help veterinarians, pet owners, farmers, and producers maintain and improve the health of animals.

News Releases

In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

Merck Animal Health Wins 2025 S&P Global Award in Best Product and Best Product Companion Animal Food Animal Categories for NUMELVI and INNOVAX® ND-IBD-ILT, Respectively

S&P Global Animal Health awarded NUMELVI® Best Companion Animal Product and INNOVAX® ND-ILT-IBD Best Food Animal Product. This is the 8th consecutive year that Merck Animal Health earned an S&P Global Award and the first time a company has won the Best Product Companion Animal and Best Product Food Animal awards in the same year.

IPPE 2026

Please complete the request form below so we can provide support and more information about our products and technologies.

De Soto, Kansas, Animal Health Manufacturing Site

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world.

Companion Animal

State-of-the-art products and services that help pets live longer, healthier lives.

News Releases

FDA Conditionally Approves Merck Animal Health’s EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

Sustainability

Investing in science-backed solutions that make a real and meaningful impact in protecting and preserving the future of our planet.

Policies and Positions

MSD Animal Health firmly supports the responsible use of antibiotics to improve and maintain the health of animals.

Animal Health and Welfare

Our commitment to animal health and welfare is central to everything we do.